Clint Allen

6.2k total citations
129 papers, 4.3k citations indexed

About

Clint Allen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Clint Allen has authored 129 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 57 papers in Immunology and 26 papers in Molecular Biology. Recurrent topics in Clint Allen's work include Cancer Immunotherapy and Biomarkers (48 papers), Immunotherapy and Immune Responses (27 papers) and Immune Cell Function and Interaction (20 papers). Clint Allen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (48 papers), Immunotherapy and Immune Responses (27 papers) and Immune Cell Function and Interaction (20 papers). Clint Allen collaborates with scholars based in United States, Japan and United Kingdom. Clint Allen's co-authors include Carter Van Waes, Paúl E. Clavijo, Jay Friedman, Ellen Moore, Ruth J. Davis, Zhong Chen, Yvette Robbins, Ravindra Uppaluri, Jeffrey Schlom and James W. Hodge and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Clint Allen

118 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clint Allen United States	40	2.4k	2.0k	1.1k	769	590	129	4.3k
Ágnes Bánkfalvi Germany	35	1.6k 0.7×	716 0.4×	1.7k 1.5×	566 0.7×	861 1.5×	136	4.2k
Hidayatullah G. Munshi United States	45	2.5k 1.1×	803 0.4×	2.3k 2.0×	482 0.6×	1.1k 1.9×	106	4.8k
Laura Strauss United States	29	2.0k 0.8×	3.2k 1.6×	1.1k 1.0×	303 0.4×	542 0.9×	46	4.5k
Tracy Tabib United States	26	1.1k 0.4×	1.7k 0.8×	1.4k 1.2×	837 1.1×	436 0.7×	55	3.8k
Nisha J. D’Silva United States	38	1.5k 0.7×	437 0.2×	2.0k 1.8×	602 0.8×	896 1.5×	109	4.6k
Magis Mandapathil Germany	21	733 0.3×	1.4k 0.7×	877 0.8×	198 0.3×	491 0.8×	47	2.7k
Leona Ling United States	28	1.9k 0.8×	2.3k 1.2×	2.2k 1.9×	360 0.5×	497 0.8×	49	5.2k
Lukas J.A.C. Hawinkels Netherlands	31	2.1k 0.9×	1.6k 0.8×	1.9k 1.6×	590 0.8×	895 1.5×	99	4.8k
María Angélica Cortez United States	32	1.7k 0.7×	1.0k 0.5×	2.6k 2.2×	765 1.0×	2.3k 3.8×	92	4.9k
Athina Giannoudis United Kingdom	22	929 0.4×	636 0.3×	828 0.7×	212 0.3×	451 0.8×	50	2.7k

Countries citing papers authored by Clint Allen

Since Specialization

Citations

This map shows the geographic impact of Clint Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clint Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clint Allen more than expected).

Fields of papers citing papers by Clint Allen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clint Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clint Allen. The network helps show where Clint Allen may publish in the future.

Co-authorship network of co-authors of Clint Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Clint Allen. A scholar is included among the top collaborators of Clint Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clint Allen. Clint Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Norberg, Scott M. & Clint Allen. (2025). Successful immunotherapy using adenovector gene therapy for the treatment of recurrent respiratory papillomatosis. Molecular Therapy. 33(11). 5313–5315.

Fabian, Kellsye P., Ginette S. Santiago-Sánchez, Michelle R. Padget, et al.. (2024). Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models. Journal for ImmunoTherapy of Cancer. 12(10). e009712–e009712. 3 indexed citations

Clavijo, Paúl E., et al.. (2024). Heterogeneous characterization of neutrophilic cells in head and neck cancers. Head & Neck. 46(10). 2591–2599. 1 indexed citations

Bracken‐Clarke, Dara, Clint Allen, Elisabetta Xue, et al.. (2024). Phase II trial of immunotherapeutic HPV vaccine PRGN-2009 with pembrolizumab before standard treatment in subjects with newly diagnosed HPV-associated oropharyngeal cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS6124–TPS6124.

Robbins, Yvette, Jay Friedman, Jason M. Redman, et al.. (2023). Tumor cell HLA class I expression and pathologic response following neoadjuvant immunotherapy for newly diagnosed head and neck cancer. Oral Oncology. 138. 106309–106309. 6 indexed citations

Allen, Clint, et al.. (2023). Egress of resident memory T cells from tissue with neoadjuvant immunotherapy: Implications for systemic anti-tumor immunity. Oral Oncology. 146. 106570–106570. 5 indexed citations

Rose, Emily, Marcela A. Ferrada, Kaitlin A. Quinn, et al.. (2021). Physician Global Assessment as a Disease Activity Measure for Relapsing Polychondritis. Arthritis Care & Research. 74(8). 1269–1276. 5 indexed citations

Nagaya, Tadanobu, Jay Friedman, Yasuhiro Maruoka, et al.. (2019). Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors. Cancer Immunology Research. 7(3). 401–413. 123 indexed citations

Greene, Sarah, Yvette Robbins, Wojciech K. Mydlarz, et al.. (2019). Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models. Clinical Cancer Research. 26(6). 1420–1431. 217 indexed citations

10.

Friedman, Jay, Ellen Moore, Paul Zolkind, et al.. (2019). Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells. Clinical Cancer Research. 26(3). 679–689. 57 indexed citations

11.

Xiao, Roy, Yi An, Wenda Ye, et al.. (2019). Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV− and HPV+ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy. Clinical Cancer Research. 25(21). 6463–6474. 25 indexed citations

12.

Clavijo, Paúl E., Jay Friedman, Yvette Robbins, et al.. (2018). Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function. Cancer Immunology Research. 7(2). 282–291. 40 indexed citations

13.

Davis, Ruth J., Ellen Moore, Paúl E. Clavijo, et al.. (2017). Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ. Cancer Research. 77(10). 2607–2619. 178 indexed citations

14.

Tran, Linda, Clint Allen, Roy Xiao, et al.. (2017). Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma. Cancer Immunology Research. 5(12). 1141–1151. 146 indexed citations

15.

Moore, Ellen, Harrison Cash, Ravindra Uppaluri, et al.. (2016). Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers. Cancer Immunology Research. 4(7). 611–620. 81 indexed citations

16.

Moore, Ellen, Paúl E. Clavijo, Ruth J. Davis, et al.. (2016). Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade. Cancer Immunology Research. 4(12). 1061–1071. 123 indexed citations

17.

Yang, Xinping, Hai Lü, Bin Yan, et al.. (2011). ΔNp63 Versatilely Regulates a Broad NF-κB Gene Program and Promotes Squamous Epithelial Proliferation, Migration, and Inflammation. Cancer Research. 71(10). 3688–3700. 101 indexed citations

18.

Lü, Hai, Xinping Yang, Praveen Duggal, et al.. (2011). TNF-α Promotes c-REL/ΔNp63α Interaction and TAp73 Dissociation from Key Genes That Mediate Growth Arrest and Apoptosis in Head and Neck Cancer. Cancer Research. 71(21). 6867–6877. 64 indexed citations

19.

Pernas, Francisco G., Clint Allen, Mary Winters, et al.. (2009). Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer. Clinical Cancer Research. 15(7). 2361–2372. 46 indexed citations

20.

Allen, Clint, Kunal Saigal, Liesl Nottingham, et al.. (2008). Bortezomib-Induced Apoptosis with Limited Clinical Response Is Accompanied by Inhibition of Canonical but not Alternative Nuclear Factor-κB Subunits in Head and Neck Cancer. Clinical Cancer Research. 14(13). 4175–4185. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact